Free Trial
Your $100 Credit Is Waiting! Get MarketBeat All Access Today
Lock In $149
Claim MarketBeat All Access Sale Promotion

Alterity Therapeutics (ATHE) Institutional Ownership

Alterity Therapeutics logo
$4.18 -0.09 (-2.11%)
Closing price 03:59 PM Eastern
Extended Trading
$4.40 +0.23 (+5.38%)
As of 06:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Institutional Ownership Changes (13F Filings) for Alterity Therapeutics (NASDAQ:ATHE)

Current
Institutional Ownership
Percentage
2.14%
Number of
Institutional Buyers
(last 12 months)
4
Total
Institutional Inflows
(last 12 months)
$930.33K
Number of
Institutional Sellers
(last 12 months)
0
Get ATHE Insider Trade Alerts

Want to know when executives and insiders are buying or selling Alterity Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

ATHE Institutional Buying and Selling by Quarter

Alterity Therapeutics Major Shareholders & Ownership History

Export
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/17/2025 Citadel Advisors LLC22,144$83K0.0%N/A0.250%
10/23/2025 HB Wealth Management LLC58,460$220K0.0%N/A0.659%
10/22/2025 Greenleaf Trust32,000$120K0.0%+88.2%0.361%
10/21/2025 Twin Lakes Capital Management LLC139,258$524K0.2%+2,250.3%1.570%
7/17/2025 Greenleaf Trust17,000$70K0.0%N/A0.192%
5/7/2025HB Wealth Management LLC37,483$129K0.0%+17.6%0.423%
2/17/2025Point72 Asset Management L.P.32,627$108K0.0%N/A0.373%
2/17/2025BNP Paribas Financial Markets8,790$29K0.0%N/A0.101%
1/15/2025HB Wealth Management LLC31,883$110K0.0%+34.1%0.436%
2/4/2022Envestnet Asset Management Inc.82,386$59K0.0%N/A0.364%


ATHE Institutional Ownership - Frequently Asked Questions

During the previous two years, the following institutional investors and hedge funds held shares of Alterity Therapeutics shares: Twin Lakes Capital Management LLC ($524K), HB Wealth Management LLC ($220K), Greenleaf Trust ($120K), Point72 Asset Management L.P. ($108K), and Citadel Advisors LLC ($83K), BNP Paribas Financial Markets ($29K).Learn more on Alterity Therapeutics' institutional investors.

2.14% of Alterity Therapeutics' stock is owned by institutional investors. Learn more on ATHE's institutional investor holdings.

The following institutional investors have purchased Alterity Therapeutics' stock in the last 24 months: Twin Lakes Capital Management LLC ($133.33K), HB Wealth Management LLC ($72.16K), Point72 Asset Management L.P. ($32.63K), Greenleaf Trust ($32K), Citadel Advisors LLC ($22.14K), and BNP Paribas Financial Markets ($8.79K).

Institutional investors have bought a total of 245,937 shares in the last 24 months. This purchase volume represents approximately $930.33K in transactions.


Related Companies

This page (NASDAQ:ATHE) was last updated on 5/21/2026 by MarketBeat.com Staff.
From Our Partners
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
SpaceX IPO hides a much bigger story
The SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...
Weiss Ratings | Sponsoredtc pixel
Satellite Images Spot Potential $10 Trillion Discovery
'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...
Altimetry | Sponsoredtc pixel